Sepax Attributes

• The first automated technology to be cleared by the US FDA for cord blood processing
• The only automated technology to be approved by the Japanese Ministry of Health
• Used by over 70% of Netcord cord blood banks - the organization of the world's leading public cord blood banks
• The only automated technology that has processed cord blood units that have been used in successful transplants
• Over 250,000 cord blood units have been successfully processed with Sepax
• The only automated technology that is used in routine regenerative medicine procedures

In addition, Sepax is the only automated technology being used in routine regenerative medicine applications with significant scientific date relating to cardiac and orthopaedic applications.